GSK
AstraZeneca hires former GSK head as CFO
November 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, dunoyer
AstraZeneca has confirmed that Marc Dunoyer has been appointed chief financial officer and will join the company’s Board as an …
GSK strikes new vaccines deal with Gates Foundation
October 30, 2013Research and Development, Sales and Marketing GSK, Gates, bmgf, vaccines
GSK and the Bill & Melinda Gates Foundation (BMGF) will invest a combined $1.8 million in early-stage research into making …
Corruption probe hits GSK
October 24, 2013Sales and Marketing China, GSK, Q3, corruption
The fallout from corruption investigations in China has hit GlaxoSmithKline, which announced third quarter sales in the country were down …
US regulator ponders Arzerra
October 22, 2013Sales and Marketing Arzerra, CLL, FDA, GSK
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …
Former GSK director joins Publicis Life Brands Resolute
October 22, 2013Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis
Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …
Travel ban ambiguity for GSK ‘s former China boss
October 17, 2013Sales and Marketing China, GSK, bribery, reilly
GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …
Janssen takes on GSK hep C drug
October 9, 2013Research and Development, Sales and Marketing GSK, GSK2336805, HCV, Janssen
Janssen Pharmaceuticals has acquired one of GlaxoSmithKline’s investigational hepatitis C treatments and will look at it in combination with various …
GSK sets malaria vaccine roll-out date to 2015
October 8, 2013Research and Development, Sales and Marketing GSK, Vaccine, malaria, rts, s
GlaxoSmithKline says it is just two years away from marketing the world’s first malaria vaccine RTS,S. This follows results from …
EMA gets first line Arzerra submission
October 7, 2013Sales and Marketing Arzerra, GSK, Genmab, blood cancer
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the European Medicines Agency (EMA) in a first line …
MHRA: Cervarix ‘in clear’
October 1, 2013Sales and Marketing GSK, Gardasil, MHRA, ceravix
Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …
Aspen buys GSK plant and thrombosis drugs for $1.1 billion
October 1, 2013Manufacturing and Production, Sales and Marketing GSK, aspen
South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …
GSK in Barclays deal
September 30, 2013Sales and Marketing GSK, Zambia, barclays, csr
GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …
The future of data disclosure in Europe
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency
The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …
Pandemrix narcolepsy U-turn by government
September 24, 2013Sales and Marketing GSK, Pandemrix, flu vaccine, government
The government has acknowledged that a GSK flu vaccine administered during the swine flu breakout could have caused children to …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
